Holding till 2013.
Let's be honest here, the entry price for investors on this stock varies widely. You have $1.25 on this board all the way to the high 8s.
Of course people are day trading this stock. Name a stock that people aren't day trading.
However, there is the pharma strategy. And that strategy is to be part of something that could be a big medical opportunity, not to mention a financial opp for investors.
With this stock, you're looking at trickle in news, but as many have said before, there are target dates for the research, studies, and all of that happens throughout the year, with expectations of big news hitting in the fall/winter.
Everyone is free to make their own decisions, and feel free to buy in December when shares, IMO will be in double digits.
News 
Market Data 
Discover 
